Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice

脉络膜新生血管 血管抑制剂 血管内皮生长因子 生物相容性 医学 黄斑变性 眼科 新生血管 视网膜 川地31 H&E染色 病理 血管生成 化学 染色 贝伐单抗 癌症研究 外科 免疫组织化学 血管内皮生长因子受体 有机化学 化疗
作者
Weinan Hu,Wenting Cai,Yan Wu,Chengda Ren,Donghui Yu,Tingting Li,Tianyi Shen,Ding Xu,Jing Yu
出处
期刊:International Journal of Nanomedicine [Dove Medical Press]
卷期号:Volume 19: 35-51 被引量:18
标识
DOI:10.2147/ijn.s428684
摘要

Background: Age-related macular degeneration (AMD) stands as the foremost cause of irreversible central vision impairment, marked by choroidal neovascularization (CNV). The prevailing clinical approach to AMD treatment relies on intravitreal injections of anti-vascular endothelial growth factor (VEGF) drugs. However, this method is encumbered by diverse complications, prompting exploration of non-invasive alternatives such as ocular administration via eye drops for anti-VEGF therapy. Methods: Two complexes, 5-FITC-CPP-Ranibizumab (5-FCR) and 5-FITC-CPP-Conbercept (5-FCC), were synthesized by incorporating the anti-VEGF drugs Ranibizumab (RBZ) or Conbercept (CBC) with cell-penetrating peptide (CPP). Circular dichroism spectrum (CD) facilitated complexes characterization. Eye drops was utilized to address laser-induced CNV in mice. Fluorescein fundus angiography (FFA) observe the CNV lesion, while FITC-dextran and IB4 dual fluorescent staining, along with hematoxylin-eosin (HE) staining, assessed in lesion size. Tissue immunofluorescence examined CD31 and VEGF expression in choroidal/retinal pigment epithelial (RPE) tissues. Biocompatibility and biosafety of 5-FCR and 5-FCC was evaluated through histological examination of various organs or cell experiments. Results: Both 5-FCR and 5-FCC exhibited favorable biocompatibility and safety profiles. VEGF-induced migration of Human umbilical vein endothelial cells (HUVECs) significantly decreased post-5-FCR/5-FCC treatment. Additionally, both complexes suppressed VEGF-induced tube formation in HUVECs. FFA results revealed a significant improvement in retinal exudation in mice. Histological examination unveiled the lesion areas in the 5-FCR and 5-FCC groups showed a significant reduction compared to the control group. Similar outcomes were observed in histological sections of the RPE-choroid-sclera flat mounts. Conclusion: In this study, utilizing the properties of CPP and two anti-VEGF drugs, we successfully synthesized two complexes, 5-FCR and 5-FCC, through a straightforward approach. Effectively delivering the anti-VEGF drugs to the target area in a non-invasive manner, suppressing the progression of laser-induced CNV. This offers a novel approach for the treatment of wet AMD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小木虫完成签到,获得积分10
刚刚
ll完成签到,获得积分20
刚刚
Seer完成签到,获得积分10
刚刚
迷雾完成签到,获得积分10
1秒前
solar完成签到,获得积分10
2秒前
秋风的应助被NiaoJiang采纳,获得10
2秒前
Estelle完成签到,获得积分10
3秒前
3秒前
gina完成签到,获得积分10
3秒前
曾sir完成签到,获得积分10
3秒前
独特觅翠完成签到,获得积分10
3秒前
虚幻曼冬完成签到,获得积分10
4秒前
陈雨柏发布了新的文献求助10
4秒前
369ninja发布了新的文献求助10
4秒前
YY完成签到,获得积分10
4秒前
槿曦完成签到 ,获得积分10
4秒前
吉吉国王完成签到,获得积分10
4秒前
疯狂学习的小聂完成签到,获得积分10
5秒前
手术缝合线完成签到 ,获得积分10
6秒前
6秒前
wanci的应助被晴天采纳,获得10
6秒前
Lizhuo完成签到,获得积分10
6秒前
银子吃好的完成签到,获得积分0
6秒前
www完成签到 ,获得积分10
6秒前
颿曦完成签到,获得积分10
6秒前
方百招完成签到,获得积分10
7秒前
Akoasm发布了新的文献求助10
7秒前
虚幻的觅露完成签到,获得积分10
7秒前
好运常在完成签到,获得积分10
8秒前
君为臣纲完成签到,获得积分0
8秒前
aaaddwdf完成签到,获得积分10
9秒前
拼搏的飞薇完成签到,获得积分10
9秒前
Archer完成签到,获得积分10
9秒前
从容的尔云完成签到 ,获得积分10
9秒前
科研菜鸟望毕业完成签到,获得积分10
9秒前
12345完成签到,获得积分10
9秒前
dandelion发布了新的文献求助10
10秒前
残夜完成签到,获得积分10
10秒前
youyuguang完成签到 ,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039